Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Philip Morris International (NY: PM )

121.69 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,482
Open 121.69
Bid (Size) 119.84 (1)
Ask (Size) 120.20 (11)
Prev. Close 121.69
Today's Range 121.69 - 121.69
52wk Range 87.23 - 128.22
Shares Outstanding 1,558,540,992
Dividend Yield 4.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Philip Morris Intl Unusual Options Activity
Via Benzinga
Philip Morris Analyst Raises Forecasts Ahead Of Q3 Earnings, But 'Consumer Elasticities Remain A Risk'
Philip Morris International will report Q3 results on Oct 22. Analyst expects the Marlboro parent company to report 7.6% revenue growth. 
Via Benzinga

Performance

YTD
+27.34%
+27.34%
1 Month
+0.36%
+0.36%
3 Month
+19.35%
+19.35%
6 Month
+31.94%
+31.94%
1 Year
+33.62%
+33.62%

More News

Read More
2 Top Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
A Closer Look at Philip Morris Intl's Options Market Dynamics
Via Benzinga
Billionaire Stan Druckenmiller Is Selling Nvidia, Apple, and Microsoft, and Buying These High-Yield Dividend Stocks Instead
Via The Motley Fool
Topics Economy
Exposures Interest Rates
3 Dividend Kings to Add to Your Portfolio for a Lifetime of Passive Income
Via The Motley Fool
What the Options Market Tells Us About Philip Morris Intl
Via Benzinga
Looking At Philip Morris Intl's Recent Unusual Options Activity
Via Benzinga
(PM) - Analyzing Philip Morris Intl's Short Interest
Via Benzinga
Going Ex-Dividend
Via Talk Markets
Topics Stocks
Exposures US Equities
Billionaire Stanley Druckenmiller Just Added This Hot Dividend Growth Stock to His Portfolio
Via The Motley Fool
“Stocks Under $1 Gaining Momentum: WBUY, KAVL, OMEX, PRTG, RJDG – Driving Innovation, Market Trends, and Growth Potential”
Via AB Newswire
Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex
From Philip Morris International
Via Business Wire
Unpacking the Latest Options Trading Trends in Philip Morris Intl
Via Benzinga
“Cardiol Therapeutics (NASDAQ: CRDL) Myocarditis Breakthrough Featured on Fox Business: CardiolRx™ Poised for Medical Impact more stocks inside…”
Via AB Newswire
Philip Morris International Increases Dividend by 3.8% to Annualized Rate of $5.40 per Share
From Philip Morris International
Via Business Wire
“Intelligent Bio (NASDAQ: INBS), SINTX Technologies (NASDAQ: SINT) Lead Market Surge, and Piedmont, Kaival, Peraso Show Strong Potential”
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
New KPMG Report Shows Illicit Cigarette Consumption Still at Worrying Levels in the European Union, With Organized Crime Moving Operations Closer to Western Countries
From Philip Morris International
Via Business Wire
NJOY Is Thriving, but Altria Needs More Than Vaping Before Investors Buy the Stock
Via The Motley Fool
Growth Stocks Across Multiple Sectors-Innovators in Action: MODD, INBS, RCAT, KAVL, WHLR”
Via AB Newswire
Exposures Product Safety
Philip Morris International To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
September Is Showing Us Just How Rough It Can Be
Via Talk Markets
Topics Economy
Exposures Interest Rates
Philip Morris International Participates in 2024 Barclays Global Consumer Staples Conference
From Philip Morris International
Via Business Wire
3 Dividend Stocks to Buy Now and Hold Forever
Via The Motley Fool
Should You Buy the 3 Highest-Yielding Dividend Stocks in the S&P 500?
Via The Motley Fool
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.